#AGBT19 Advances in Genome Biology and Technology Preview

This year for the first time in three years the annual Advances in Genome Biology and Technology conference (#AGBT19) will be held back in Marco Island Florida, where it traditionally was held for many years. Those not familiar with AGBT, it is a specialty conference that began in the 1990’s during the run-up to the … Read more

The Fluidigm C1™ Single Cell Auto Prep System

The Fluidigm C1 single cell microfluidic chamber showing a capture
The Fluidigm C1 IFC chip, borrowed from Fluidigm’s Spec Sheet

Every human being came from a single cell. While that fact may not be so obvious in our day-to-day routine, the power of a single cell is observed with the burst of research activity in stem cells and induced pluripotent stem cells (and also see the Nobel Prize winner for 2012 in Physiology or Medicine, Shinya Yamanaka, who discovered the reprogramming process). In cancer research, the concept of cancer stem cells has developed into a major effort into identifying and characterizing circulating tumor cells (“CTC’s”) by which metastatses occurs. This was a major topic of discussion at the Spring 2013 AACR meeting in Washington DC, as well as a recent Next Generation Dx meeting (also in Washington DC). In many other areas of human disease biology, the inherently heterogeneous nature of tissues in general point to the need to analyze biology at a much finer resolution.

Read more

Is there room for 90 providers of genomics software?

Image courtesy Libertas Academica via Flickr.

“Let a hundred flowers bloom, let a hundred schools of thought contend”, Mao once said during the Revolutionary Days of 1957. Now in the middle of a genomics revolution, it feels that way in the market for genomics software to analyze next-generation sequencing data. New companies are being formed, large software and hardware firms are expanding into the life sciences, and others are offering in addition to software options the implementation of a cloud-based service.

Read more

Virtual Research from a Million Datasets

Image courtesy of <a href=”http://www.flickr.com/photos/jurvetson/”>jervetson</a> via Flickr.

Way back in 1997 a company launched one of the first commercial expression microarrays. The company was Affymetrix, the technology was micro-lithography, and the excitement around this new technology was palpable in the days before even the Human Genome Project had been completed.

Read more